Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Other Non-Current Liabilities (2016 - 2026)

Champions Oncology has reported Other Non-Current Liabilities over the past 16 years, most recently at $27000.0 for Q1 2026.

  • For Q1 2026, Other Non-Current Liabilities fell 90.53% year-over-year to $27000.0; the TTM value through Jan 2026 reached $27000.0, down 90.53%, while the annual FY2025 figure was $85000.0, 78.8% down from the prior year.
  • Other Non-Current Liabilities for Q1 2026 was $27000.0 at Champions Oncology, down from $46000.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $660000.0 in Q3 2022 and troughed at $27000.0 in Q1 2026.
  • A 5-year average of $357117.6 and a median of $391000.0 in 2022 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: surged 172.73% in 2022 and later plummeted 90.53% in 2026.
  • Year by year, Other Non-Current Liabilities stood at $624000.0 in 2022, then decreased by 23.72% to $476000.0 in 2023, then crashed by 31.93% to $324000.0 in 2024, then crashed by 85.8% to $46000.0 in 2025, then tumbled by 41.3% to $27000.0 in 2026.
  • Business Quant data shows Other Non-Current Liabilities for CSBR at $27000.0 in Q1 2026, $46000.0 in Q4 2025, and $66000.0 in Q3 2025.